Director/PDMR Shareholding

Bellway

12/11/2025 16:54

RNS Number : 3065H

Bellway PLC

12 November 2025

 

BELLWAY p.l.c. ('the Company')

NOTIFICATION OF TRANSACTIONS OF

PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

12 NOVEMBER 2025

 

The Company announces that pursuant to the Company's 2013 Performance Share Plan ('2013 Plan'), the following exercises of nil-cost options and subsequent sale of 12.5p ordinary shares in the capital of the Company to meet income tax and National Insurance liabilities arising from the exercises. Based on the performance over the period and in line with the Remuneration Policy, 56.4% of the award vested.

The sale of shares took place on 11 November 2025 at an average price of £27.67. 

Award
Number of vestedshares subject to exercise (including dividend equivalent shares)
Number of shares sold
Number of shares retained (transferred to spouse as noted in the notification below)
Jason Honeyman
2013 Plan
41,940
19,752
22,188
Simon Scougall
2013 Plan
9,836
4,633
5,203

 

The relevant notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulations.

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
1 Jason Honeyman
2 Joanne Honeyman
2
Reason for the notification
a)
Position/status
1 Director (PDMR)
2 PCA of PDMR
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bellway p.l.c.
b)
LEI
213800CY4L3HST4FGZ98
4
Details of the transaction(s): section to date; to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
12.5p ordinary shares
GB0000904986
b)
Nature of the transaction
1a Exercise of award granted in November 2022 under the Company's Performance Share Plan and associated dividend accrual shares.
1b Sale of shares to cover income tax and National Insurance liability due on the exercise of this award.
1c+2 Transfer of shares to Joanne Honeyman (PCA).
c)
Price(s) and volume(s)
Price(s) Volume(s)
1a Nil 41,940
1b £27.67 19,752
1c+2 Nil 22,188
d)
Aggregated information
Aggregated volume
Price
N/A
N/A
e)
Date of the transaction
11 November 2025
f)
Place of the transaction
London Stock Exchange (XLON)

 

 

1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
1 Simon Scougall
2 Joanne Scougall
2
Reason for the notification
a)
Position/status
1 Director (PDMR)
2 PCA of PDMR
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Bellway p.l.c.
b)
LEI
213800CY4L3HST4FGZ98
4
Details of the transaction(s): section to date; to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
12.5p ordinary shares
GB0000904986
b)
Nature of the transaction
1a Exercise of award granted in November 2022 under the Company's Performance Share Plan and associated dividend accrual shares.
1b Sale of shares to cover income tax and National Insurance liability due on the exercise of this award.
1c+2 Transfer of shares to Joanne Scougall (PCA).
c)
Price(s) and volume(s)
Price(s) Volume(s)
1a Nil 9,836
1b £27.67 4,633
1c+2 Nil 5,203
d)
Aggregated information
Aggregated volume
Price
N/A
N/A
e)
Date of the transaction
11 November 2025
f)
Place of the transaction
London Stock Exchange (XLON)

 

Name of contact and telephone number for queries:

Phil Hope

Finance Director and Company Secretary

Bellway p.l.c.

Tel: 0191 217 0717

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHKZMMMVZFGKZM